ORIGINAL ARTICLE

Immortalized HEK 293 Kidney Cell Lines as Models of Renal Cells: Friends or Foes?

Cesare Achilli, Annarita Ciana, Giampaolo Minetti

Laboratories of Biochemistry, Department of Biology and Biotechnology, University of Pavia, Pavia, Italy

Abstract

The immortalized cell lines derived from human embryonic kidney, named HEK 293, are extensively used as models of human renal cells in in vitro studies. Nevertheless, ample evidence in the literature shows that HEK 293 cells display genotypic and phenotypic characteristics that differ substantially from primary kidney cells, with potential detrimental effects on the quality of the experimental results. Among the differences documented between HEK 293 and renal cells, there is an altered pattern of expression of many proteins involved in the development and physiological functions of the kidney. Methionine sulfoxide reductase (Msr) enzymes are ubiquitous components of the cellular machinery, evolved to counteract the damages inflicted to methionine residues by oxidative stress, particularly intense in kidney tissues. In this article, we have compared the levels of expression of several different Msr enzymes in human kidney and in a HEK 293 strain and have observed significant differences between the two cell types.

Keywords: HEK 293; kidney; methionine sulfoxide reductase; MsrA; MsrB

Received: 02 June 2018; Accepted after revision: 27 July 2018; Published: 23 August 2018

Author for correspondence: Giampaolo Minetti, Laboratories of Biochemistry, Department of Biology and Biotechnology, University of Pavia, via AgostinoBassi, 21, Pavia, Italy. Email: giampaolo.minetti@unipv.it

How to cite: Achilli C. et al. Immortalized HEK 293 kidney cell lines as models of renal cells: friends or foes? J Controversies Biomed Res. 2018;4(1):6–9

Doi: http://dx.doi.org/10.15586/jcbmr.2018.26

Copyright: Achilli C. et al.

License: This open access article is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). http://creativecommons.org/licenses/by/4.0

 

Introduction

In 1951, the first immortalized human cell strain (designed as HeLa) was developed by propagation of poliomyelitis virus in tissue cultures prepared from epidermoid carcinoma of the cervix (1). Since then, more than 3600 new cell lines from over 150 species have been developed, revolutionizing the scientific world. In fact, immortalized cell lines are extensively used in many branches of basic biomedical research, from the study of gene function to generation of artificial tissues. They have several advantages over primary cells, such as the ability to proliferate virtually indefinitely, cost-effectiveness, easiness of handling, and no ethical restrictions associated with the use of animal or human tissues.

Cell culture studies provide a valuable complement for in vivo experiments; however, the necessary condition to use this strategy is that the immortalized cells display and maintain functional features as close as possible to related primary cells.

Among the many advantages there are, however, some critical issues that could dramatically affect the goodness of the results, such as contamination by other cell lines or by mycoplasma, and the misidentification of cell lines. About these problems, it is estimated that up to one third of cell lines are imposters (25).

Owing to their altered genome and karyotype, immortalized cell lines should be considered as cancerous cells, and consequently their native functions and responsiveness to stimuli could be different from those of related primary cells (6). In addition, the use of cultures at high-passage numbers could further induce the genotypic/phenotypic variability, which could also vary from one cell line to another (7). For these reasons, the immortalized cell lines cannot represent a priori a reliable model of their original source tissue and could provide controversial results. In order to avoid these mistakes, the current recommendations by the National Institutes of Health are to verify the results obtained using cell lines by running experiments with primary cells, and to authenticate the cell lines that are in use.

In 1977 it was reported, for the first time, that human embryonic kidney cells, obtained from an aborted fetus, were transformed by exposure to sheared human adenovirus type-5 DNA (8), and therefore they became an immortalized cell line. The superinfected cells, designated human embryonic kidney 293 (HEK 293) cells, and their derivative cell lines, such as the one transformed in 1987 by Epstein–Barr virus and named HEK 293T (9), are extensively used in biomedical and biotechnology research as a model of kidney epithelial cells. However, these renal cell strains express only a limited number of typical markers of the kidney development, such as those of the mesenchymal-epithelial transition, but not others, such as those of the differentiated tubular segments, proximal tubules, and collecting ducts. Surprisingly, HEK 293 cells express many neuromarkers, such as those typical of the neurofilament and other neurospecific metabolic enzymes (10).

HEK 293 cell line and its derivatives are among the most widely used human cell lines in biomedical experimentation, and the fact that properties of both neuron and kidney lineages coexist in the same strain could have significant implications for experiments in which a secure kidney cell control is required. In addition, it is unknown whether this cell line originally obtained from developing renal tissue can be representative of primary cells of an adult kidney, nor of which specific renal cell types. For these ambiguities, it would be safer not to use these cellular lines as a model of renal cells, especially for the study of kidney function.

The energy production necessary for the tubular reabsorption in the kidney relies on aerobic metabolism and oxidative phosphorylation, which implies, as a side effect, the release of high levels of reactive oxygen species (ROS). The renal cells activate several signaling pathways to maintain ROS at low levels. An excess of ROS would be very aggressive to several cellular components, including amino acids such as methionine, whose sulfur atom is easily oxidized to generate the two diastereoisomers of methionine sulfoxide. Since aberrant oxidation of methionine alters the physiological properties of many proteins, particularly high levels of methionine sulfoxide reductase enzymes (Msr) are expressed, among the other tissues, in the kidney. Msrs are ubiquitous enzymes of the cellular weaponry that has evolved to prevent or revert the damage inflicted by elevated levels of oxidants to sensitive cellular components. Msrs, in particular, perform the reconversion of methionine sulfoxide to methionine (1113). Msrs were classified on the basis of their stereoselectivity toward the two diastereoisomers of methionine sulfoxide: MsrAs reduce methionine-S-sulfoxide, whereas MsrBs reduce methionine-R-sulfoxide (14).

Very little is known on the expression of Msr enzymes in the cell lineages used in vitro as a model of human kidney cells. Considering the importance of this class of enzymes in the protection of the kidney against oxidative stress, and the extensive and inescapable use of immortalized cell lines for the in vitro studies on renal cell function, this lacuna should be filled up. Here, we have therefore compared the levels of some Msr enzymes in human kidney cells and HEK 293T lineage by quantitative analysis of their transcripts.

Materials and Methods

Culture of HEK 293T cells

HEK 293T cells were grown in adhesion in Dulbecco’s modified Eagle’s medium (supplemented with 10% of heat-inactivated bovine fetal serum, L-glutamine, streptomycin, and penicillin) at 37°C in the presence of 5% CO2 and harvested at about 90% confluence by gentle stirring. The cells were then washed once with PBS, centrifuged at 500 g for 10 min at 4°C, and stored at −80°C.

RNA extraction and reverse transcription

The human kidney cDNA required to perform the quantitative reverse transcription polymerase chain reaction (qRT-PCR) was purchased from Thermo Fisher Scientific (Milano, Italy), while RNA of HEK 293T was extracted and then reverse transcribed, as follows: Total RNA was extracted using Trizol® reagent (Thermo Fisher Scientific, Milano, Italy) according to the supplier’s instructions. The RNA obtained was dissolved in diethyl pyrocarbonate (DEPC)-treated MilliQ® water and the concentration was determined by spectrophotometric assay at 260 nm. After extraction, RNA was immediately reverse transcribed. First-strand cDNA was synthesized using 2–10 μg total RNA using the High Capacity cDNA Archive Kit (Thermo Fisher Scientific, Milano, Italy) according to the manufacturer’s recommendations. The samples were then stored at −80°C.

qRT-PCR

The expression levels of MsrA, MsrB1, MsrB2, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were evaluated using qRT-PCR based on the TaqMan® Gene Expression Assay (Thermo Fisher Scientific, Milano, Italy; Assay ID: Hs00737165_m1 for MsrA; Hs00249482_m1 for MsrB1; Hs00255292_m1 for MsrB2; and Hs99999905_m1 for GAPDH) according to the manufacturer’s instruction. Standard curves were constructed by serial dilution of cDNA samples for the different Msrs with DEPC-treated MilliQ® water. The amplification reactions were performed in a 96-well microtiter plate in a thermocycler for quantitative PCR (Mx 3000P and MxPro software, Agilent Technologies, Milano, Italy). The normalization of the results was carried out by comparison with the relative expression levels of the housekeeping gene GAPDH in the same cell type. Through the calibration curve the relative abundance of the transcript was obtained for each sample. The value obtained for each Msr gene in every cell type was compared with the corresponding value obtained for GAPDH. This procedure allowed a direct comparison of the expression levels of the transcripts in the examined cell types.

Results

In this study, we examined the mRNA levels of MsrA, MsrB1, and MsrB2, the typical forms of Msrs expressed in mammalian tissues, and for which the presence in the human renal tissues has been documented for adult and embryonic kidney (1113). The presence of MsrA, MsrB1, and MsrB2 transcripts was evaluated by qRT-PCR in cDNA obtained from HEK 293T cells and total human kidney. The latter, which ideally includes the cDNA obtained from all the cell types of which the adult kidney is composed, represents an excellent reference to perform a comparison with a HEK 293 lineage, whose exact attribution is still ignored and, paradoxically, should be a heterogeneous mix of almost all the cell types present in the body. This technique allows the quantification of transcripts for a gene of interest by comparing them with the levels of transcript of a housekeeping gene in the same cell type, thus permitting direct comparison of absolute levels of transcripts in different tissues. The results obtained were normalized over the expression levels of GAPDH, used as housekeeping gene. Using this method it could be verified that the levels of MsrA, MsrB1, and MsrB2 transcripts were, respectively, 80, 25, and 6 times lower in HEK 293T than in the human kidney tissue (Figure 1).



Fig 1

Figure 1. Levels of MsrA, MsrB1, and MsrB2 transcripts in human kidney and HEK 293T cells, analyzed by qRT-PCR. The mRNA levels of the three proteins were normalized over the levels of GAPDH mRNA.

Discussion

The debate on the authenticity of HEK 293 cells has been going on for 20 years and does not seem to have reached a conclusion. Every study conducted to unmask in an incontrovertible manner the “double face” of this immortalized cell line represents a small step toward the truth. The data collected in this paper seem to corroborate the evidence widely described in the literature concerning the inadequacy of HEK 293 lineage as a model of renal cells.

The results are also in agreement with enzymatic assays and Western blotting analysis preliminarily conducted on cell extracts of HEK 293T, essentially as we reported for several human blood cells and murine organs (13), in which very low levels of Msr activity and protein expression emerged in this cell line (data not shown).

The low expression of Msrs in HEK 293T cells could be due to the alteration of the energy metabolism that is commonly found in tumor cells, with enhanced glycolytic activity and diminished mitochondrial metabolic capacity (15). A slow mitochondrial cellular respiration is associated with a decreased production of ROS; therefore, tumor cells could also thrive in the absence of elaborate enzymatic defense/repair systems.

The limited expression of Msrs is also in agreement with the hypothesis that HEK 293T cells are not actually renal cells but more likely a neuronal lineage (16). In neurons, lower levels of expression of Msrs with respect to kidney have been described (11, 12). Data on the neuronal genotype of HEK 293T, and the lower expression of Msr enzymes in most human brain tissues compared to renal cells, seem to be consistent with the results presented here. Our observations seem to corroborate the data reported in the literature, which show how the HEK 293 cell line and its derivatives, including HEK 293T, are not cell lines suitable as a model of renal cells, and therefore should be used with caution in studies focused on the physiology of kidney cells (10).

Conclusion

HEK 293 cells and their derivative HEK 293T are defined as human embryonic kidney cells and under this denomination are widely used experimentally in cell biology studies. The long-going debate around their true origin, which is probably from adrenal cells that display many features of neuronal cells and could have been preferentially transformed by adenovirus when the cell line was originally established, could not help to officially change their denomination. We have reported here that HEK 293T cells express very low levels of Msr enzymes (MsrA, MsrB1, and MsrB2), which instead are highly expressed in human kidney cells. This data coincides with the hypothesis, suggested by several researchers, that HEK 293T cells actually are not renal cells and, for this reason, are not a good model of human kidney cells.

Acknowledgments

Part of this work was supported with funds from the “Ministero dell’Istruzione, Università e Ricerca Scientifica” Italy (PRIN 2006).

Conflict of Interest

The author declares no conflicts of interest with respect to research, authorship, and/or publication of this article.

References

  1. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695–710. http://dx.doi.org/10.1084/jem.97.5.695
  2. Lacroix M. Persistent use of “false” cell lines. Int J Cancer. 2008;122:1–4. http://dx.doi.org/10.1002/ijc.23233
  3. American Type Culture Collection Standards Development Organization Workgroup ASN-0002. Cell line misidentification: The beginning of the end. Nat Rev Cancer. 2010;10:441–8. http://dx.doi.org/10.1038/nrc2852
  4. Capes-Davis A, Theodosopoulos G, Atkin I, Drexler HG, Kohara A, MacLeod RA, et al. Check your cultures! A list of cross-contaminated or misidentified cell lines. Int J Cancer. 2010;127:1–8. http://dx.doi.org/10.1002/ijc.25242
  5. Horbach SPJM, Halffman W. The ghosts of HeLa: How cell line misidentification contaminates the scientific literature. PLoS One. 2017;12:e0186281. http://dx.doi.org/10.1371/journal.pone.0186281
  6. Kavsan VM, Iershov AV, Balynska OV. Immortalized cells and one oncogene in malignant transformation: Old insights on new explanation. BMC Cell Biol. 2011;12:23. http://dx.doi.org/10.1186/1471-2121-12-23
  7. Hughes P, Marshall D, Reid Y, Parkes H, Gelber C. The costs of using unauthenticated, over-passaged cell lines: How much more data do we need? Biotechniques. 2007;43:575–82. http://dx.doi.org/10.2144/000112598
  8. Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36:59–74. http://dx.doi.org/10.1099/0022-1317-36-1-59
  9. DuBridge RB, Tang P, Hsia HC, Leong PM, Miller JH, Calos MP. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol. 1987;7:379–87. http://dx.doi.org/10.1128/MCB.7.1.379
  10. Stepanenko AA, Dmitrenko VV. HEK293 in cell biology and cancer research: Phenotype, karyotype, tumorigenicity, and stress-induced genome-phenotype evolution. Gene. 2015;569:182–90. http://dx.doi.org/10.1016/j.gene.2015.05.065
  11. Kuschel L, Hansel A, Schönherr R, Weissbach H, Brot N, Hoshi T, et al. Molecular cloning and functional expression of a human peptide methionine sulfoxidereductase (hMsrA). FEBS Lett. 1999;456:17–21. http://dx.doi.org/10.1016/S0014-5793(99)00917-5
  12. Jung S, Hansel A, Kasperczyk H, Hoshi T, Heinemann SH. Activity, tissue distribution and site-directed mutagenesis of a human peptide methionine sulfoxide reductase of type B: hCBS1. FEBS Lett. 2002;527:91–4. http://dx.doi.org/10.1016/S0014-5793(02)03171-X
  13. Achilli C, Ciana A, Rossi A, Balduini C, Minetti G. Neutrophil granulocytes uniquely express, among human blood cells, high levels of Methionine-sulfoxide-reductase enzymes. J Leukoc Biol. 2008;83:181–9. http://dx.doi.org/10.1189/jlb.0707492
  14. Achilli C, Ciana A, Minetti G. The discovery of methionine sulfoxide reductase enzymes: An historical account and future perspectives. Biofactors. 2015;41:135–52. http://dx.doi.org/10.1002/biof.1214
  15. Mikirova NA, Casciari JJ, Gonzalez MJ, Miranda-Massari JR, Riordan NH, Duconge J. Bioenergetics of human cancer cells and normal cells during proliferation and differentiation. Cancer Ther OncolInt J. 2017;3:1–8. http://dx.doi.org/10.19080/CTOIJ.2017.03.555623
  16. Shaw G, Morse S, Ararat M, Graham FL. Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. FASEB J. 2002;16:869–71. http://dx.doi.org/10.1096/fj.01-0995fje